A Study of mRNA-1010 Seasonal Influenza Vaccine in Healthy Adults

Completed · Phase 1/Phase 2 · Has a placebo group

Conditions studied: Seasonal Influenza

In brief

The study comprises 3 parts: Phase 1/2, Phase 2 Northern Hemisphere (NH), and Phase 2 extension. The primary objective of this study is to evaluate the safety, reactogenicity, and humoral immunogenicity of mRNA-1010 vaccine.

Key facts

Study ID
NCT04956575
Run by
ModernaTX, Inc.
People needed
885
Starts
2021-07-06
Expected to finish
2022-09-27
Last updated by the study team
2023-10-27

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: accepted.

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.